RecruitingNot ApplicableNCT05693363
Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
Sponsor
University Hospital, Ghent
Enrollment
40 participants
Start Date
Jan 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
In this pilot study the investigators propose the intraoperative use of a high-resolution PET-CT imaging system which can assess resection margins and lymph node status in the operating room. This will allow for a faster and stepwise assessment (estimated to be under 10 minutes per specimen), enabling the surgeon to decide on subsequent surgical steps after each previous assessment.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient is 18 years of age or older.
- Patient with suspected or confirmed lung malignancies
- Patient is indicated to undergo thoracic surgery.
- Patient is estimated to be compliant for study participation by the investigator.
- Patient has freely given his/her informed consent to participate in this study.
Exclusion Criteria5
- Patient has general or local contra-indications for thoracic surgery.
- Patient has active infection.
- Blood glucose level over 200 mg/dL on the day of surgery.
- Pregnancy or lactation.
- Patient participated in other clinical studies with radiation exposure of more than 1 mSv in the past year
Interventions
DEVICEAURA10 Specimen Imager
High-resolution specimen imaging using the AURA10 PET-CT specimen imager during thoracic surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05693363
Related Trials
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
NCT072919211 location
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
NCT071431102 locations
DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
NCT071091547 locations
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
NCT068856971 location
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT015809821 location